Akoya biosciences to showcase new data on phenocycler-fusion at the aacr annual meeting 2022

Marlborough, mass., april 06, 2022 (globe newswire) -- akoya biosciences, inc., (nasdaq: akya), the spatial biology company®, today announced that two important milestones on advancing the speed and scale of its spatial phenotyping solutions, will be presented during the american association for cancer research (aacr) 2022 annual meeting in new orleans, april 8 to 13. first, the company will showcase the industry's first 100-plex dataset for deep spatial phenotyping at single cell resolution, across an entire tissue sample. second, they will preview a new universal chemistry to enable accelerated validation of biomarkers discovered using deep spatial phenotyping.
AKYA Ratings Summary
AKYA Quant Ranking